サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1120374

世界のゲノムバイオマーカー市場：考察と予測 (2028年まで)

Global Genomic Biomarkers Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 114 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界のゲノムバイオマーカー市場：考察と予測 (2028年まで)
出版日: 2022年08月30日
発行: QYResearch
ページ情報: 英文 114 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、ゲノムバイオマーカー (Genomic Biomarkers) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界のゲノムバイオマーカーの市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Oncology
    • Cardiovascular Diseases
    • Neurological Diseases
    • Others
  • 市場：アプリケーション別
    • 世界のゲノムバイオマーカーの市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Diagnostic and Research Laboratories
    • Hospitals
    • Others
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のゲノムバイオマーカーの市場展望 (2017-2028)
  • ゲノムバイオマーカーの市場成長トレンド：地域別
    • ゲノムバイオマーカー 市場規模：地域別: 2017 VS 2021 VS 2028
    • ゲノムバイオマーカーの市場規模実績：地域別 (2017-2022)
    • ゲノムバイオマーカーの市場規模予測：地域別 (2023-2028)
  • ゲノムバイオマーカー 市場動向
    • ゲノムバイオマーカー 業界動向
    • ゲノムバイオマーカー 市場の促進要因
    • ゲノムバイオマーカー 市場の課題
    • ゲノムバイオマーカー 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界のゲノムバイオマーカーの上位企業：収益別
    • 世界のゲノムバイオマーカーの上位企業：収益別 (2017-2022)
    • 世界のゲノムバイオマーカーの収益シェア：企業別 (2017-2022)
  • 世界のゲノムバイオマーカーの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：ゲノムバイオマーカーの収益
  • 世界のゲノムバイオマーカー 市場集中度
    • 世界のゲノムバイオマーカー 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： ゲノムバイオマーカーの収益 2021
  • ゲノムバイオマーカーの主要企業の本社および事業エリア
  • 主要企業 ゲノムバイオマーカーの製品ソリューションおよびサービス
  • 市場参入時期： ゲノムバイオマーカー 市場
  • M&A, 拡張計画

第4章 ゲノムバイオマーカー 内訳データ：タイプ別

  • 世界のゲノムバイオマーカーの市場規模実績：タイプ別 (2017-2022)
  • 世界のゲノムバイオマーカーの市場規模予測：タイプ別 (2023-2028)

第5章 ゲノムバイオマーカー 内訳データ：アプリケーション別

  • 世界のゲノムバイオマーカーの市場規模実績：アプリケーション別 (2017-2022)
  • 世界のゲノムバイオマーカーの市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米のゲノムバイオマーカー 市場規模 (2017-2028)
  • 北米のゲノムバイオマーカー 市場規模：タイプ別
    • 北米のゲノムバイオマーカー 市場規模：タイプ別 (2017-2022)
    • 北米のゲノムバイオマーカー 市場規模：タイプ別 (2023-2028)
    • 北米のゲノムバイオマーカーの市場シェア：タイプ別 (2017-2028)
  • 北米のゲノムバイオマーカー 市場規模：アプリケーション別
    • 北米のゲノムバイオマーカー 市場規模：アプリケーション別 (2017-2022)
    • 北米のゲノムバイオマーカー 市場規模：アプリケーション別 (2023-2028)
    • 北米のゲノムバイオマーカーの市場シェア：アプリケーション別 (2017-2028)
  • 北米のゲノムバイオマーカー 市場規模：国別
    • 北米のゲノムバイオマーカー 市場規模：国別 (2017-2022)
    • 北米のゲノムバイオマーカー 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のゲノムバイオマーカー 市場規模 (2017-2028)
  • 欧州のゲノムバイオマーカー 市場規模：タイプ別
    • 欧州のゲノムバイオマーカー 市場規模：タイプ別 (2017-2022)
    • 欧州のゲノムバイオマーカー 市場規模：タイプ別 (2023-2028)
    • 欧州のゲノムバイオマーカーの市場シェア：タイプ別 (2017-2028)
  • 欧州のゲノムバイオマーカー 市場規模：アプリケーション別
    • 欧州のゲノムバイオマーカー 市場規模：アプリケーション別 (2017-2022)
    • 欧州のゲノムバイオマーカー 市場規模：アプリケーション別 (2023-2028)
    • 欧州のゲノムバイオマーカーの市場シェア：アプリケーション別 (2017-2028)
  • 欧州のゲノムバイオマーカー 市場規模：国別
    • 欧州のゲノムバイオマーカー 市場規模：国別 (2017-2022)
    • 欧州のゲノムバイオマーカー 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 ゲノムバイオマーカー 市場規模 (2017-2028)
  • アジア太平洋地域 ゲノムバイオマーカー 市場規模：タイプ別
    • アジア太平洋地域 ゲノムバイオマーカー 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 ゲノムバイオマーカー 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 ゲノムバイオマーカーの市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 ゲノムバイオマーカー 市場規模：アプリケーション別
    • アジア太平洋地域 ゲノムバイオマーカー 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 ゲノムバイオマーカー 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 ゲノムバイオマーカーの市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 ゲノムバイオマーカー 市場規模：地域別
    • アジア太平洋地域 ゲノムバイオマーカー 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 ゲノムバイオマーカー 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカのゲノムバイオマーカー 市場規模 (2017-2028)
  • ラテンアメリカのゲノムバイオマーカー 市場規模：タイプ別
    • ラテンアメリカのゲノムバイオマーカー 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカのゲノムバイオマーカー 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカのゲノムバイオマーカーの市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカのゲノムバイオマーカー 市場規模：アプリケーション別
    • ラテンアメリカのゲノムバイオマーカー 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカのゲノムバイオマーカー 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカのゲノムバイオマーカーの市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカのゲノムバイオマーカー 市場規模：国別
    • ラテンアメリカのゲノムバイオマーカー 市場規模：国別 (2017-2022)
    • ラテンアメリカのゲノムバイオマーカー 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカのゲノムバイオマーカー 市場規模 (2017-2028)
  • 中東・アフリカのゲノムバイオマーカー 市場規模：タイプ別
    • 中東・アフリカのゲノムバイオマーカー 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカのゲノムバイオマーカー 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカのゲノムバイオマーカーの市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカのゲノムバイオマーカー 市場規模：アプリケーション別
    • 中東・アフリカのゲノムバイオマーカー 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカのゲノムバイオマーカー 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカのゲノムバイオマーカーの市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカのゲノムバイオマーカー 市場規模：国別
    • 中東・アフリカのゲノムバイオマーカー 市場規模：国別 (2017-2022)
    • 中東・アフリカのゲノムバイオマーカー 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Thermo Fisher Scientific
  • Roche
  • Aepodia
  • Myriad Genetics
  • Eurofins Scientific
  • QIAGEN
  • Bio-Rad Laboratories
  • Genomic Health
  • Liquid Genomics
  • Epigenomics
  • AROS Applied Biotechnology

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Genomic Biomarkers Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Oncology
  • Table 3. Key Players of Cardiovascular Diseases
  • Table 4. Key Players of Neurological Diseases
  • Table 5. Key Players of Others
  • Table 6. Global Genomic Biomarkers Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 7. Global Genomic Biomarkers Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 8. Global Genomic Biomarkers Market Size by Region (2017-2022) & (US$ Million)
  • Table 9. Global Genomic Biomarkers Market Share by Region (2017-2022)
  • Table 10. Global Genomic Biomarkers Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 11. Global Genomic Biomarkers Market Share by Region (2023-2028)
  • Table 12. Genomic Biomarkers Market Trends
  • Table 13. Genomic Biomarkers Market Drivers
  • Table 14. Genomic Biomarkers Market Challenges
  • Table 15. Genomic Biomarkers Market Restraints
  • Table 16. Global Genomic Biomarkers Revenue by Players (2017-2022) & (US$ Million)
  • Table 17. Global Genomic Biomarkers Revenue Share by Players (2017-2022)
  • Table 18. Global Top Genomic Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Biomarkers as of 2021)
  • Table 19. Ranking of Global Top Genomic Biomarkers Companies by Revenue (US$ Million) in 2021
  • Table 20. Global 5 Largest Players Market Share by Genomic Biomarkers Revenue (CR5 and HHI) & (2017-2022)
  • Table 21. Key Players Headquarters and Area Served
  • Table 22. Key Players Genomic Biomarkers Product Solution and Service
  • Table 23. Date of Enter into Genomic Biomarkers Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
  • Table 26. Global Genomic Biomarkers Revenue Market Share by Type (2017-2022)
  • Table 27. Global Genomic Biomarkers Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. Global Genomic Biomarkers Revenue Market Share by Type (2023-2028)
  • Table 29. Global Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. Global Genomic Biomarkers Revenue Share by Application (2017-2022)
  • Table 31. Global Genomic Biomarkers Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 32. Global Genomic Biomarkers Revenue Share by Application (2023-2028)
  • Table 33. North America Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
  • Table 34. North America Genomic Biomarkers Market Size by Type (2023-2028) & (US$ Million)
  • Table 35. North America Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
  • Table 36. North America Genomic Biomarkers Market Size by Application (2023-2028) & (US$ Million)
  • Table 37. North America Genomic Biomarkers Market Size by Country (2017-2022) & (US$ Million)
  • Table 38. North America Genomic Biomarkers Market Size by Country (2023-2028) & (US$ Million)
  • Table 39. Europe Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
  • Table 40. Europe Genomic Biomarkers Market Size by Type (2023-2028) & (US$ Million)
  • Table 41. Europe Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
  • Table 42. Europe Genomic Biomarkers Market Size by Application (2023-2028) & (US$ Million)
  • Table 43. Europe Genomic Biomarkers Market Size by Country (2017-2022) & (US$ Million)
  • Table 44. Europe Genomic Biomarkers Market Size by Country (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Genomic Biomarkers Market Size by Type (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Genomic Biomarkers Market Size by Application (2023-2028) & (US$ Million)
  • Table 49. Asia Pacific Genomic Biomarkers Market Size by Region (2017-2022) & (US$ Million)
  • Table 50. Asia Pacific Genomic Biomarkers Market Size by Region (2023-2028) & (US$ Million)
  • Table 51. Latin America Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
  • Table 52. Latin America Genomic Biomarkers Market Size by Type (2023-2028) & (US$ Million)
  • Table 53. Latin America Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
  • Table 54. Latin America Genomic Biomarkers Market Size by Application (2023-2028) & (US$ Million)
  • Table 55. Latin America Genomic Biomarkers Market Size by Country (2017-2022) & (US$ Million)
  • Table 56. Latin America Genomic Biomarkers Market Size by Country (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Genomic Biomarkers Market Size by Type (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Genomic Biomarkers Market Size by Application (2023-2028) & (US$ Million)
  • Table 61. Middle East and Africa Genomic Biomarkers Market Size by Country (2017-2022) & (US$ Million)
  • Table 62. Middle East and Africa Genomic Biomarkers Market Size by Country (2023-2028) & (US$ Million)
  • Table 63. Thermo Fisher Scientific Company Details
  • Table 64. Thermo Fisher Scientific Business Overview
  • Table 65. Thermo Fisher Scientific Genomic Biomarkers Product
  • Table 66. Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
  • Table 67. Thermo Fisher Scientific Recent Developments
  • Table 68. Roche Company Details
  • Table 69. Roche Business Overview
  • Table 70. Roche Genomic Biomarkers Product
  • Table 71. Roche Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
  • Table 72. Roche Recent Developments
  • Table 73. Aepodia Company Details
  • Table 74. Aepodia Business Overview
  • Table 75. Aepodia Genomic Biomarkers Product
  • Table 76. Aepodia Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
  • Table 77. Aepodia Recent Developments
  • Table 78. Myriad Genetics Company Details
  • Table 79. Myriad Genetics Business Overview
  • Table 80. Myriad Genetics Genomic Biomarkers Product
  • Table 81. Myriad Genetics Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
  • Table 82. Myriad Genetics Recent Developments
  • Table 83. Eurofins Scientific Company Details
  • Table 84. Eurofins Scientific Business Overview
  • Table 85. Eurofins Scientific Genomic Biomarkers Product
  • Table 86. Eurofins Scientific Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
  • Table 87. Eurofins Scientific Recent Developments
  • Table 88. QIAGEN Company Details
  • Table 89. QIAGEN Business Overview
  • Table 90. QIAGEN Genomic Biomarkers Product
  • Table 91. QIAGEN Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
  • Table 92. QIAGEN Recent Developments
  • Table 93. Bio-Rad Laboratories Company Details
  • Table 94. Bio-Rad Laboratories Business Overview
  • Table 95. Bio-Rad Laboratories Genomic Biomarkers Product
  • Table 96. Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
  • Table 97. Bio-Rad Laboratories Recent Developments
  • Table 98. Genomic Health Company Details
  • Table 99. Genomic Health Business Overview
  • Table 100. Genomic Health Genomic Biomarkers Product
  • Table 101. Genomic Health Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
  • Table 102. Genomic Health Recent Developments
  • Table 103. Liquid Genomics Company Details
  • Table 104. Liquid Genomics Business Overview
  • Table 105. Liquid Genomics Genomic Biomarkers Product
  • Table 106. Liquid Genomics Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
  • Table 107. Liquid Genomics Recent Developments
  • Table 108. Epigenomics Company Details
  • Table 109. Epigenomics Business Overview
  • Table 110. Epigenomics Genomic Biomarkers Product
  • Table 111. Epigenomics Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
  • Table 112. Epigenomics Recent Developments
  • Table 113. AROS Applied Biotechnology Company Details
  • Table 114. AROS Applied Biotechnology Business Overview
  • Table 115. AROS Applied Biotechnology Genomic Biomarkers Product
  • Table 116. AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
  • Table 117. AROS Applied Biotechnology Recent Developments
  • Table 118. Research Programs/Design for This Report
  • Table 119. Key Data Information from Secondary Sources
  • Table 120. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Genomic Biomarkers Market Share by Type: 2021 VS 2028
  • Figure 2. Oncology Features
  • Figure 3. Cardiovascular Diseases Features
  • Figure 4. Neurological Diseases Features
  • Figure 5. Others Features
  • Figure 6. Global Genomic Biomarkers Market Share by Application: 2021 VS 2028
  • Figure 7. Diagnostic and Research Laboratories Case Studies
  • Figure 8. Hospitals Case Studies
  • Figure 9. Others Case Studies
  • Figure 10. Genomic Biomarkers Report Years Considered
  • Figure 11. Global Genomic Biomarkers Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 12. Global Genomic Biomarkers Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Genomic Biomarkers Market Share by Region: 2021 VS 2028
  • Figure 14. Global Genomic Biomarkers Market Share by Players in 2021
  • Figure 15. Global Top Genomic Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Biomarkers as of 2021)
  • Figure 16. The Top 10 and 5 Players Market Share by Genomic Biomarkers Revenue in 2021
  • Figure 17. North America Genomic Biomarkers Market Size YoY (2017-2028) & (US$ Million)
  • Figure 18. North America Genomic Biomarkers Market Size Market Share by Type (2017-2028)
  • Figure 19. North America Genomic Biomarkers Market Size Market Share by Application (2017-2028)
  • Figure 20. North America Genomic Biomarkers Market Size Share by Country (2017-2028)
  • Figure 21. United States Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Canada Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Europe Genomic Biomarkers Market Size YoY (2017-2028) & (US$ Million)
  • Figure 24. Europe Genomic Biomarkers Market Size Market Share by Type (2017-2028)
  • Figure 25. Europe Genomic Biomarkers Market Size Market Share by Application (2017-2028)
  • Figure 26. Europe Genomic Biomarkers Market Size Share by Country (2017-2028)
  • Figure 27. Germany Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. France Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. U.K. Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Italy Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Russia Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Nordic Countries Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Asia-Pacific Genomic Biomarkers Market Size YoY (2017-2028) & (US$ Million)
  • Figure 34. Asia Pacific Genomic Biomarkers Market Size Market Share by Type (2017-2028)
  • Figure 35. Asia Pacific Genomic Biomarkers Market Size Market Share by Application (2017-2028)
  • Figure 36. Asia Pacific Genomic Biomarkers Market Size Share by Region (2017-2028)
  • Figure 37. China Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Japan Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. South Korea Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Southeast Asia Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. India Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Australia Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 43. Latin America Genomic Biomarkers Market Size YoY (2017-2028) & (US$ Million)
  • Figure 44. Latin America Genomic Biomarkers Market Size Market Share by Type (2017-2028)
  • Figure 45. Latin America Genomic Biomarkers Market Size Market Share by Application (2017-2028)
  • Figure 46. Latin America Genomic Biomarkers Market Size Share by Country (2017-2028)
  • Figure 47. Mexico Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Brazil Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Middle East & Africa Genomic Biomarkers Market Size YoY (2017-2028) & (US$ Million)
  • Figure 50. Middle East and Africa Genomic Biomarkers Market Size Market Share by Type (2017-2028)
  • Figure 51. Middle East and Africa Genomic Biomarkers Market Size Market Share by Application (2017-2028)
  • Figure 52. Middle East and Africa Genomic Biomarkers Market Size Share by Country (2017-2028)
  • Figure 53. Turkey Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Saudi Arabia Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. UAE Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
  • Figure 57. Roche Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
  • Figure 58. Aepodia Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
  • Figure 59. Myriad Genetics Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
  • Figure 60. Eurofins Scientific Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
  • Figure 61. QIAGEN Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
  • Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
  • Figure 63. Genomic Health Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
  • Figure 64. Liquid Genomics Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
  • Figure 65. Epigenomics Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
  • Figure 66. AROS Applied Biotechnology Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
  • Figure 67. Bottom-up and Top-down Approaches for This Report
  • Figure 68. Data Triangulation
  • Figure 69. Key Executives Interviewed
目次

This research report focuses on the Genomic Biomarkers Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Genomic Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Oncology
    • 1.2.3 Cardiovascular Diseases
    • 1.2.4 Neurological Diseases
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Genomic Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Diagnostic and Research Laboratories
    • 1.3.3 Hospitals
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Genomic Biomarkers Market Perspective (2017-2028)
  • 2.2 Genomic Biomarkers Growth Trends by Region
    • 2.2.1 Genomic Biomarkers Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Genomic Biomarkers Historic Market Size by Region (2017-2022)
    • 2.2.3 Genomic Biomarkers Forecasted Market Size by Region (2023-2028)
  • 2.3 Genomic Biomarkers Market Dynamics
    • 2.3.1 Genomic Biomarkers Industry Trends
    • 2.3.2 Genomic Biomarkers Market Drivers
    • 2.3.3 Genomic Biomarkers Market Challenges
    • 2.3.4 Genomic Biomarkers Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Genomic Biomarkers Players by Revenue
    • 3.1.1 Global Top Genomic Biomarkers Players by Revenue (2017-2022)
    • 3.1.2 Global Genomic Biomarkers Revenue Market Share by Players (2017-2022)
  • 3.2 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Genomic Biomarkers Revenue
  • 3.4 Global Genomic Biomarkers Market Concentration Ratio
    • 3.4.1 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarkers Revenue in 2021
  • 3.5 Genomic Biomarkers Key Players Head office and Area Served
  • 3.6 Key Players Genomic Biomarkers Product Solution and Service
  • 3.7 Date of Enter into Genomic Biomarkers Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Genomic Biomarkers Breakdown Data by Type

  • 4.1 Global Genomic Biomarkers Historic Market Size by Type (2017-2022)
  • 4.2 Global Genomic Biomarkers Forecasted Market Size by Type (2023-2028)

5 Genomic Biomarkers Breakdown Data by Application

  • 5.1 Global Genomic Biomarkers Historic Market Size by Application (2017-2022)
  • 5.2 Global Genomic Biomarkers Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Genomic Biomarkers Market Size (2017-2028)
  • 6.2 North America Genomic Biomarkers Market Size by Type
    • 6.2.1 North America Genomic Biomarkers Market Size by Type (2017-2022)
    • 6.2.2 North America Genomic Biomarkers Market Size by Type (2023-2028)
    • 6.2.3 North America Genomic Biomarkers Market Share by Type (2017-2028)
  • 6.3 North America Genomic Biomarkers Market Size by Application
    • 6.3.1 North America Genomic Biomarkers Market Size by Application (2017-2022)
    • 6.3.2 North America Genomic Biomarkers Market Size by Application (2023-2028)
    • 6.3.3 North America Genomic Biomarkers Market Share by Application (2017-2028)
  • 6.4 North America Genomic Biomarkers Market Size by Country
    • 6.4.1 North America Genomic Biomarkers Market Size by Country (2017-2022)
    • 6.4.2 North America Genomic Biomarkers Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Genomic Biomarkers Market Size (2017-2028)
  • 7.2 Europe Genomic Biomarkers Market Size by Type
    • 7.2.1 Europe Genomic Biomarkers Market Size by Type (2017-2022)
    • 7.2.2 Europe Genomic Biomarkers Market Size by Type (2023-2028)
    • 7.2.3 Europe Genomic Biomarkers Market Share by Type (2017-2028)
  • 7.3 Europe Genomic Biomarkers Market Size by Application
    • 7.3.1 Europe Genomic Biomarkers Market Size by Application (2017-2022)
    • 7.3.2 Europe Genomic Biomarkers Market Size by Application (2023-2028)
    • 7.3.3 Europe Genomic Biomarkers Market Share by Application (2017-2028)
  • 7.4 Europe Genomic Biomarkers Market Size by Country
    • 7.4.1 Europe Genomic Biomarkers Market Size by Country (2017-2022)
    • 7.4.2 Europe Genomic Biomarkers Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Genomic Biomarkers Market Size (2017-2028)
  • 8.2 Asia-Pacific Genomic Biomarkers Market Size by Type
    • 8.2.1 Asia-Pacific Genomic Biomarkers Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Genomic Biomarkers Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Genomic Biomarkers Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Genomic Biomarkers Market Size by Application
    • 8.3.1 Asia-Pacific Genomic Biomarkers Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Genomic Biomarkers Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Genomic Biomarkers Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Genomic Biomarkers Market Size by Region
    • 8.4.1 Asia-Pacific Genomic Biomarkers Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Genomic Biomarkers Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Genomic Biomarkers Market Size (2017-2028)
  • 9.2 Latin America Genomic Biomarkers Market Size by Type
    • 9.2.1 Latin America Genomic Biomarkers Market Size by Type (2017-2022)
    • 9.2.2 Latin America Genomic Biomarkers Market Size by Type (2023-2028)
    • 9.2.3 Latin America Genomic Biomarkers Market Share by Type (2017-2028)
  • 9.3 Latin America Genomic Biomarkers Market Size by Application
    • 9.3.1 Latin America Genomic Biomarkers Market Size by Application (2017-2022)
    • 9.3.2 Latin America Genomic Biomarkers Market Size by Application (2023-2028)
    • 9.3.3 Latin America Genomic Biomarkers Market Share by Application (2017-2028)
  • 9.4 Latin America Genomic Biomarkers Market Size by Country
    • 9.4.1 Latin America Genomic Biomarkers Market Size by Country (2017-2022)
    • 9.4.2 Latin America Genomic Biomarkers Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Genomic Biomarkers Market Size (2017-2028)
  • 10.2 Middle East & Africa Genomic Biomarkers Market Size by Type
    • 10.2.1 Middle East & Africa Genomic Biomarkers Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Genomic Biomarkers Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Genomic Biomarkers Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Genomic Biomarkers Market Size by Application
    • 10.3.1 Middle East & Africa Genomic Biomarkers Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Genomic Biomarkers Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Genomic Biomarkers Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Genomic Biomarkers Market Size by Country
    • 10.4.1 Middle East & Africa Genomic Biomarkers Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Genomic Biomarkers Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Details
    • 11.1.2 Thermo Fisher Scientific Business Overview
    • 11.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction
    • 11.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2017-2022)
    • 11.1.5 Thermo Fisher Scientific Recent Developments
  • 11.2 Roche
    • 11.2.1 Roche Company Details
    • 11.2.2 Roche Business Overview
    • 11.2.3 Roche Genomic Biomarkers Introduction
    • 11.2.4 Roche Revenue in Genomic Biomarkers Business (2017-2022)
    • 11.2.5 Roche Recent Developments
  • 11.3 Aepodia
    • 11.3.1 Aepodia Company Details
    • 11.3.2 Aepodia Business Overview
    • 11.3.3 Aepodia Genomic Biomarkers Introduction
    • 11.3.4 Aepodia Revenue in Genomic Biomarkers Business (2017-2022)
    • 11.3.5 Aepodia Recent Developments
  • 11.4 Myriad Genetics
    • 11.4.1 Myriad Genetics Company Details
    • 11.4.2 Myriad Genetics Business Overview
    • 11.4.3 Myriad Genetics Genomic Biomarkers Introduction
    • 11.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2017-2022)
    • 11.4.5 Myriad Genetics Recent Developments
  • 11.5 Eurofins Scientific
    • 11.5.1 Eurofins Scientific Company Details
    • 11.5.2 Eurofins Scientific Business Overview
    • 11.5.3 Eurofins Scientific Genomic Biomarkers Introduction
    • 11.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2017-2022)
    • 11.5.5 Eurofins Scientific Recent Developments
  • 11.6 QIAGEN
    • 11.6.1 QIAGEN Company Details
    • 11.6.2 QIAGEN Business Overview
    • 11.6.3 QIAGEN Genomic Biomarkers Introduction
    • 11.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2017-2022)
    • 11.6.5 QIAGEN Recent Developments
  • 11.7 Bio-Rad Laboratories
    • 11.7.1 Bio-Rad Laboratories Company Details
    • 11.7.2 Bio-Rad Laboratories Business Overview
    • 11.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction
    • 11.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2017-2022)
    • 11.7.5 Bio-Rad Laboratories Recent Developments
  • 11.8 Genomic Health
    • 11.8.1 Genomic Health Company Details
    • 11.8.2 Genomic Health Business Overview
    • 11.8.3 Genomic Health Genomic Biomarkers Introduction
    • 11.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2017-2022)
    • 11.8.5 Genomic Health Recent Developments
  • 11.9 Liquid Genomics
    • 11.9.1 Liquid Genomics Company Details
    • 11.9.2 Liquid Genomics Business Overview
    • 11.9.3 Liquid Genomics Genomic Biomarkers Introduction
    • 11.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2017-2022)
    • 11.9.5 Liquid Genomics Recent Developments
  • 11.10 Epigenomics
    • 11.10.1 Epigenomics Company Details
    • 11.10.2 Epigenomics Business Overview
    • 11.10.3 Epigenomics Genomic Biomarkers Introduction
    • 11.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2017-2022)
    • 11.10.5 Epigenomics Recent Developments
  • 11.11 AROS Applied Biotechnology
    • 11.11.1 AROS Applied Biotechnology Company Details
    • 11.11.2 AROS Applied Biotechnology Business Overview
    • 11.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction
    • 11.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2017-2022)
    • 11.11.5 AROS Applied Biotechnology Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer